Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts

Blood, Vol. 110, Issue 8, 2889-2898, October 15, 2007
This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

Cited2 is required for normal hematopoiesis in the murine fetal liver
Blood Chen et al. 110: 2889

Supplemental materials for: Chen et al, Vol. 110, Issue 8, 2889-2898.

Files in this Data Supplement:

  • Document 1. Supplemental materials and methods (PDF, 90.7 KB)

  • Figure S1. Decreased fetal liver cellularity in Cited2−/− embryos at 14.5 dpc and 15.5 dpc (JPG, 32.3 KB). -
    Fetal livers from 14.5 dpc and 15.5 dpc were harvested and single cell suspension was prepared by passing through a 1-mL pipette and filtered through 100-µm cell strainer. Cell number was counted using a hemocytometer. (A) At 14.5 dpc, Cited2−/− fetal liver (n=6) displayed significantly decreased cellularity compared to Cited2+/+ controls (n=7; P<.01). (B) Reduced cellularity was consistently observed in Cited2−/− fetal liver at 15.5 dpc (n=11) compared to Cited2+/+ controls (n=13; P<.01). Error bars are SEM.






  • Figure S2. Decreased frequency of CD45+ LSK cells in Cited2−/− fetal liver (JPG, 131 KB). -
    (A) Fetal liver cells from Cited2−/− (n=3) and Cited2+/+ littermate control (n=4) at 14.5 dpc were stained with PE-conjugated lineage markers, PerCP-Cy5.5-conjugated CD45.2, APC-conjugated-c-Kit, and FITC-conjugated Sca-1 antibodies, and the percentage of CD45+ LSK cells were analyzed as shown by the representative lineage gates. (B) The frequency of CD45+ LSK was compared between Cited2−/− and Cited2+/+ littermate control and revealed significant reduction in Cited2−/− fetal liver (P<.01; average ± SD).






  • Figure S3. Decreased CFU frequency of hematopoietic progenitor cells in Cited2−/− fetal liver (JPG, 45.5 KB). -
    Fetal liver cells (2 × 104) from each sample were plated in triplicate cultures of methylcellulose-based medium supplemented with 3 units/mL Epo, 10 ng/mL mouse recombinant IL-3, 10 ng/mL human recombinant IL-6, and 50 ng/mL mouse recombinant stem cell factor. The number of BFU-E, CFU-GM, and CFU-GEMM was determined after 7 to 12 days of culture. (A) At 13.5 dpc, the number of BFU-E, CFU-GM, and CFU-GEMM was significantly reduced in Cited2−/− fetal livers (n=5) compared to the wild type littermate controls (n=5). (B) At 14.5 dpc, decreased numbers of BFU-E, CFU-GM, and CFU-GEMM were observed in Cited2−/− fetal livers (n=4) compared to the wild type littermate controls (n=3). (C) Decreased numbers of BFU-E, CFU-GM, and CFU-GEMM were observed in Cited2−/− fetal liver (n=4) compared to the wild type littermate control (n=6) at 15.5 dpc. In addition, Cited2+/− fetal livers also showed decreased colony formation at corresponding stages (n=4 at 13.5 dpc, n=5 at 14.5 dpc, and n=4 at 15.5 dpc.). Error bars are SEM.






  • Figure S4. Chimerism analysis in mice with Cited2+/+ and Cited2−/− primary and secondary transplants (JPG, 53.7 KB). -
    Chimerism analysis showed high donor chimerism in multiple lineages in mice with Cited2+/+ and Cited2−/− primary transplants (A) and significantly reduced donor chimerism in mice with Cited2−/− (n=3) versus Cited2+/+ (n=3) secondary transplants (B). Error bars are SEM.






This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020